Poseida Therapeutics, Inc. is a clinical-stage biopharmaceutical company. The Company has discovered and are developing a broad portfolio of product candidates in a variety of indications based on its core platforms, including its non-viral piggyBac ... Read more
CNBC
CNBC
MarketWatch
MarketWatch
Access detailed stock analysis from LSEG including analyst price target estimates.